1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Dyslipidemia in 1 studies
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Present study was conducted to investigate the effects of rosuvastatin combined with fasudil on rabbits with dyslipidemia." | 7.81 | Effects of rosuvastatin combined with fasudil therapy on rabbits with dyslipidemia. ( Li, Z; Lian, H; Liang, Q; Zeng, F; Zheng, D, 2015) |
| "Present study was conducted to investigate the effects of rosuvastatin combined with fasudil on rabbits with dyslipidemia." | 3.81 | Effects of rosuvastatin combined with fasudil therapy on rabbits with dyslipidemia. ( Li, Z; Lian, H; Liang, Q; Zeng, F; Zheng, D, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Z | 1 |
| Lian, H | 1 |
| Liang, Q | 1 |
| Zeng, F | 1 |
| Zheng, D | 1 |
1 other study available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Dyslipidemia
| Article | Year |
|---|---|
Effects of rosuvastatin combined with fasudil therapy on rabbits with dyslipidemia.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Drug Therapy, Combination; Dyslipidemias; Ma | 2015 |